SPECC1L: A Protein with Multiple Coiled-Coil Domains and Involved in Cellular Processes

Target Name: SPECC1L

NCBI ID: G23384

SPECC1L

SPECC1L: A Protein with Multiple Coiled-Coil Domains and Involved in Cellular Processes

SPECC1L, or Sperm antigen with calponin homology and coiled-coil domains 1-like, is a protein that is expressed in a variety of tissues throughout the body, including the brain, spleen, heart, and testes. It is characterized by the presence of acalponin homology, a region of the protein that is similar to the calcium-binding protein calponin, as well as multiple coiled-coil domains.

The calponin gene is located on chromosome X and has been implicated in a number of physiological processes, including fertilization, DNA replication, and cell signaling. The protein encoded by this gene is a member of the calponin gene family and is involved in the regulation of a variety of cellular processes.

SPECC1L is a 180-kDa protein that is expressed in a variety of tissues, including the brain, spleen, heart, and testes. It is primarily localized to the endoplasmic reticulum (ER) and is thought to play a role in regulating the levels of a variety of proteins in the ER.

One of the defining features of SPECC1L is its ability to form multiple coiled-coil domains. These domains can interact with a variety of different proteins and are involved in the regulation of a wide range of cellular processes. In addition to its coiled-coil domains, SPECC1L also contains a region of amino acids that is similar to the calponin gene and is involved in the regulation of fertilization.

SPECC1L has been shown to play a role in a variety of cellular processes, including fertilization, DNA replication, and cell signaling. It is also involved in the regulation of the levels of several proteins in the ER, including the transcription factor p53. In addition, SPECC1L has been shown to play a role in the development and progression of cancer, and is often used as a potential drug target or biomarker.

Given its involvement in a wide range of cellular processes, it is likely that SPECC1L would be a valuable drug target or biomarker. Studies have shown that inhibiting the activity of SPECC1L has the potential to be a effective treatment for a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders. In addition, the presence of multiple coiled-coil domains in SPECC1L makes it a promising candidate for small molecule inhibitors.

In conclusion, SPECC1L is a protein that is characterized by the presence of acalponin homology, multiple coiled-coil domains, and its involvement in a wide range of cellular processes. Its ability to form multiple coiled-coil domains and its involvement in the regulation of cellular processes make it a promising candidate for drug targeting or biomarker development. Further research is needed to fully understand the role of SPECC1L in cellular processes and its potential as a drug target or biomarker.

Protein Name: Sperm Antigen With Calponin Homology And Coiled-coil Domains 1 Like

Functions: Involved in cytokinesis and spindle organization. May play a role in actin cytoskeleton organization and microtubule stabilization and hence required for proper cell adhesion and migration

The "SPECC1L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SPECC1L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets